Literature DB >> 6747450

Epidemiology of acoustic neuromas.

M Tos, J Thomsen.   

Abstract

In Denmark one surgical team, during the last 7 years, has performed about 80 per cent of all acoustic neuroma surgery. Because of this centralization, in such a limited population as that of Denmark, we have attempted to make a epidemiological survey of all diagnosed tumours in the period from 1976 to 1983. Systematic and prospective records were made by the authors of all patients with translabyrinthine operations, and data on patients with suboccipital operations were collected retrospectively from the six neurosurgical departments in Denmark. The average annual incidence was 8 tumours per million inhabitants, with the highest incidence of approximately 13 tumours per million occurring in Copenhagen County. The incidence reported in previously published autopsy series is 800-900 times higher and the following may serve as an explanation for this enormous difference: Autopsy series are in all probability based on highly selected cases; they are predominantly based on elderly people and the incidence is not directly applicable to the population at large. Several of the silent tumours from the autopsy series were located in the cochlea or in the labyrinth and not in the internal ear canal. The conclusion from our study is that both the knowledge and data available at present are insufficient to serve as a basis for an actual calculation of incidence and prevalence of acoustic neuromas.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6747450     DOI: 10.1017/s0022215100147292

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  15 in total

1.  Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67.

Authors:  T H Lesser; R C Janzer; P Kleihues; U Fisch
Journal:  Skull Base Surg       Date:  1991

2.  Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.

Authors:  C L Wu; N Thakker; W Neary; G Black; R Lye; R T Ramsden; A P Read; D G Evans
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

3.  Vertigo: a review of common peripheral and central vestibular disorders.

Authors:  Timothy L Thompson; Ronald Amedee
Journal:  Ochsner J       Date:  2009

4.  Incidence of vestibular schwannomas in the United States.

Authors:  Varun R Kshettry; Jason K Hsieh; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

5.  The translabyrinthine approach for the removal of large acoustic neuromas.

Authors:  M Tos; J Thomsen
Journal:  Arch Otorhinolaryngol       Date:  1989

6.  Natural history of acoustic neuromas.

Authors:  G E Valvassori; M Shannon
Journal:  Skull Base Surg       Date:  1991

7.  Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.

Authors:  D G Evans; R Lye; W Neary; G Black; T Strachan; A Wallace; R T Ramsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

8.  BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Authors:  Frauke Kramer; Timo Stöver; Athanasia Warnecke; Marc Diensthuber; Thomas Lenarz; Kirsten Wissel
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

9.  Prevalence of hearing loss among people aged 65 years and over: screening and hearing aid provision.

Authors:  P S Wilson; D M Fleming; I Donaldson
Journal:  Br J Gen Pract       Date:  1993-10       Impact factor: 5.386

10.  Neurofibromatosis type 2 appears to be a genetically homogeneous disease.

Authors:  S A Narod; D M Parry; J Parboosingh; G M Lenoir; M Ruttledge; G Fischer; R Eldridge; R L Martuza; M Frontali; J Haines
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.